Trial no.:
|
PACTR201604001577314 |
Date of Approval:
|
10/04/2016 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
Dexamethasone versus Dexmedetomidine as Local Anesthetic Adjuvants in Ultrasound Guided Transversus Abdominis Plane Block for Total Abdominal Hysterectomies |
Official scientific title |
Dexamethasone versus Dexmedetomidine as Local Anesthetic Adjuvants in Ultrasound Guided Transversus Abdominis Plane Block for Total Abdominal Hysterectomies |
Brief summary describing the background
and objectives of the trial
|
The transversus abdominis plane (TAP) block is most often used to provide surgical anesthesia for minor, superficial procedures on the lower abdominal wall, or postoperative analgesia for procedures below the umbilicus providing anesthesia to the ipsilateral lower abdomen below the umbilicus. The TAP block was shown to reduce the need for postoperative opioid use, increase the time to first request for further analgesia, and provide more effective pain relief, while decreasing opioid related side effects such as sedation and postoperative nausea and vomiting. The provision of effective postoperative analgesia is of key importance to facilitate early ambulation and prevention of postoperative morbidity. The analgesic regimen needs to meet the goals of providing safe, effective analgesia, with minimal side effects. Many additives to local anesthetics used to prolong the duration of analgesia for peripheral nerve blocks have been studied which include epinephrine, clonidine, buprenorphine, tramadol, sodium bicarbonate, midazolam, dexamethasone, dexmedetomidine, Fentanyl, ketamine and neostigmine.The objective is to compare efficacy and safety of dexmedetomidine and dexamethasone as local anesthetic adjuvant in TAP block. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia,Obstetrics and Gynecology,Surgery |
Sub-Disease(s) or condition(s) being studied |
Fertility-female |
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/04/2015 |
Actual trial start date |
01/04/2015 |
Anticipated date of last follow up |
31/12/2015 |
Actual Last follow-up date |
31/12/2015 |
Anticipated target sample size (number of participants) |
54 |
Actual target sample size (number of participants) |
54 |
Recruitment status |
Completed |
Publication URL |
|
|